ABSTRACT The bimane fluorescent labels, monobromobimane, dibromobimane, and monobromotrimethylammoniobimane, are derivatives of syn-9,10-dioxabimane:1,5-diazabicyclo[3.3.0]octa-3,6-diene-2,8-dione. They efficiently label hemoglobin (reactive thiol groups), membrane proteins, and glutathione of normal human red cells under physiological conditions. Monobromobimane and dibromobimane are effective on intact cells while red cell membranes may be impermeable to the positively charged monobromotrimethylammoniobimane, the latter being effective only on lysed cells. These bimane labels provide a class of labeling agents that may have wide applicability in biological materials. syn-9,10-Dioxabimanes, a new class of compounds, are highly fluorescent (1). Exceptions to this generalization are the essentially nonfluorescent bromoderivatives, illustrated by a monobromobimane (mBBr) (I), a dibromobimane (bBBr) (II), and a monobromotrimethylammoniobimane (qBBr) (III). We have now found that these three bromobimanes are highly efficient labeling agents for cells, proteins, and small molecules like glutathione, giving rise to highly fluorescent derivatives. The fluorescent derivatives are very stable in air and under irradiation. The labeling procedures are simple and can be carried out rapidly under physiological conditions. We shall describe in the present article the use of these reagents on normal human red cells.
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MATERIALS AND METHODS
Bromobimanes. The synthesis of the bromobimanes is described elsewhere (1) . mBBr and bBBr were dissolved in acetonitrile and the 50 mM stock solutions were stored in the dark; the solutions are stable for at least 2 months. The salt, qBBr, was dissolved in aqueous buffer (pH 7.4) shortly before use; the 1-4 mM solutions have a half-life at 220C of approximately 4 hr.
Red Cells. Human blood, anticoagulated with heparin, was obtained from normal individuals. The buffy coat was removed after centrifugation; the red cells were washed twice with 135 mM NaCI/10 mM phosphate buffer, pH 7.4, and resuspended in the same buffer to a packed cell volume of 5-10%. Ghosts were obtained from the cells by the procedure of Steck and Kant (2) . Hemoglobin solutions were prepared by the centrifugation of lysed red cells at 22,000 X g for 30 min, followed by dialysis of the membrane-free supernatants against 10 mM phosphate buffer, pH 7.4.
Reactions of Bromobimanes with Intact Cells, Lysates, and Hemoglobin Solutions. The reagents were added in a ratio of 5-20 ,umol of reagent per ml of packed red cells (1-4 moles of reagent per mole of hemoglobin). Usually [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Aul of the stock solution was used per ml of cell suspension of 5-10% packed cell volume. The reagent solution was placed in a dry test tube and the-sample (cell suspension, hemoglobin solution) was added with rapid mixing. A stock solution (50 mM) of the mBBr reagent could be diluted with buffer to 1-2 mM before it was mixed with a sample. The bBBr compound, which is less soluble in water, was not diluted. qBBr was dissolved in buffer immediately before use. The buffer used in most cases was 135 mM NaCl/10 mM phosphate, pH 7.4, but other buffers at the same and at different pH values were also used. The labeling was completed by incubation of the reaction mixture at various temperatures for 2-60 min. The reaction mixture was then processed for one or more of the specific analyses outlined below.
Preparation and Analysis of Cell Components. The solubilization of membrane proteins and subsequent electrophoresis on sodium dodecyl sulfate (NaDodSO4)/acrylamide slab gels, lipid extraction from ghosts, and globin preparation from hemoglobin solution and its fractionation into a and ( chains were carried out by established methods (3) (4) (5) (6) . The nonprotein SH groups were analyzed in a metaphosphoric acid extract and the hemoglobin SH groups were analyzed as described (7) . After NaDodSO4 gel electrophoresis, the slabs were fixed in metha- Fig. 3 . Over the range of 1-4 mol of mBBr per mol of hemoglobin, the increased fluorescence intensity of the isolated globin paralleled a decrease in the number of reactive SH groups of the hemoglobin. The fluorescence reached a maximum after reaction of two SH groups per mole of hemoglobin. In addition, when the reactive SH groups were first blocked through alkylation with iodoacetamide (9), the degree of bimane labeling was sharply diminished (2-8% of that found for unblocked hemoglobin; see Fig. 3 ). Titration with S,S'-dithiobis(2-nitrobenzoic acid) of the SH groups still present in both the iodoacetamide-blocked control and the iodoacetamide-blocked sample after treatment Biophysical Aspects of Labeling. The absorption maxima for the bromobimanes varied substantially with structure, with a shift of 10 nm to longer wavelengths for the change from mBBr to bBBr. However, replacement of the second bromine by a trimethylammonio group, as in qBBr, led to a shift of -18 nm for the change from mBBr to qBBr. We might estimate approximately 29 nm for the shift in maximum for the change from bBBr to qBBr. The absorption maximum for mB-labeled globin (385 nm) is the same as that for bB-labeled globin, but at considerably longer wavelengths than that for qB-labeled globin (370 nm). Parallel differences exist for bimane-labeled GSH (390 compared to 375 nm). Absorption spectra of metaphosphoric acid extracts of bimane-labeled cells show maxima similar to those for the corresponding bimane-labeled GSH (see Table 2 ).
The emission of bimane-labeled globins and GSH varies in maximum from 477 to 484 nm, corresponding to a color best described by "baby blue" or "turquoise." The quantum yields of fluorescence for mB-and bB-labeled globins and GSH vary from 0.18 to 0.33, while those for the qB-labeled materials are appreciably lower, between 0.07 and 0.13. Absorption and emission data are summarized in Table 2 . 
DISCUSSION
A moderate number of fluorescent moieties have been incorporated into a variety of molecules for use as fluorescent labeling agents. Fluorescein and rhodamine, linked to the amino groups of proteins or lipids via a thioureido link generated from an isothiocyanate, are among the most widely applied moieties (11) (12) (13) (14) (15) (16) . The labeling reaction of these compounds is relatively slow and is normally carried out at pH 9.5 (often with the added complication of the labeling agent being carried on Celite), which may lead to substantial damage to organized biological material such as cells (12) (13) (14) . The most serious disadvantage Q) 4- Parellelism of fluorescence intensity of mB-labeled globin and the number of SH groups reacted in original hemoglobin as a function of the molar ratio of mBBr labeling agent and hemoglobin. Hemoglobin was prepared as described in the caption to Fig. 2 . An aliquot was treated with iodoacetamide (9), then dialyzed against 10 mM phosphate buffer, pH 7.4. The hemoglobin solutions and the iodoacetamide-treated hemoglobin solutions were treated with mBBr (1-4 mol/mol of hemoglobin) for 60 min at 230C. Samples were dialyzed to remove any excess reagent prior to SH group analysis. 0, SH groups reacted; *, fluorescence intensity; A, fluorescence in iodoacetamide-treated sample (blocked SH group).
accruing to the use of fluorescein-and rhodamine-labeled materials is, however, the fading that occurs during observation under the illumination of the fluorescence microscope. Fading of a lipid-soluble fluorescein derivative made difficult the measurements of lateral diffusion rates in malignant and normal cells (15) . It then becomes necessary to use visual intensification microscopy (16) to follow these labels for any length of time, a procedure that works for rhodamine-labeled material but is less successful for fluorescein-labeled material because of fading.
Fluorescamine has been introduced for the labeling of proteins and cells (17) (18) (19) (20) (21) . In cells, it is mainly the lipid amino groups that are labeled, and the fluorescence fades rapidly under the microscope.
The high reactivity of maleimide double bonds towards thiol groups has been used by Kanaoka and his group (22, 23) in the design of labeling agents that become fluorescent only after reaction with the thiol group. Although capable of considerable variation with respect to the fluorescing moiety, a three-ring structure seems to be the minimum required size. A fluorescence-generating hydrolysis reaction competes with the thiollabeling reaction. No studies on the application of fluorogenic maleimides to intact cells have appeared.
We have described in the present article a new class of fluorescent labeling agents, the bromobimanes, that possess the following useful characteristics: .g., conversion of bBBr to qBBr) .
We have applied the labeling agents to red cells not only as a model for the labeling procedure, but also because of the possibility of obtaining information about the accessibility of reactive groups under physiological conditions. The disappearance of two SH groups per hemoglobin molecule, coupled with the demonstration that only the : chain of the globin is labeled implies strongly that only the two cysteine-#93 SH groups are labeled. Cat hemoglobin carries reactive groups on both a and 13 chains, and bromobimane labeling leads to fluorescence in both a and 13 chains. Other cells are readily labeled by bromobimanes; e.g., lymphocytes, fibroblasts, and slime mold cells at physiological pH (unpublished results).
The chemistry of the reaction is best illustrated for glutathione reacting with mBBr (Eq. 1). The identity of the groups within membrane proteins that are labeled is at present unknown. We presume that the small amount of labeling of "lipid" (i.e., chloroform/methanol-soluble material) also involves protein (lipoprotein), but it is possible that a small number of amino groups (phosphatidylethanolamine) of the phospholipid could be attacked by the labeling agent. The fact that higher molecular weight bands replace those normally found in NaDodSO4 gels of membrane proteins separated by electrophoresis after treatment with bBBr, but not after treatment with mBBr, implies that the bifunctional labeling agent produces some crosslinking of membrane proteins. It will be of considerable interest to identify those proteins that participate in the crosslinking process.
The failure of qBBr to label intact cells coupled with its efficient labeling of the membrane proteins and intracellular proteins of lysed cells implies quite strongly that the positively charged labeling agent does not penetrate cell membranes and that no reactive groups are present in that region of the membrane accessible to a hydrophilic agent on the outside of a human red cell. In contrast, membrane proteins are labeled after lysis. It is tempting to conclude that reactive SH groups are located on the cytoplasmic face of the membrane and to speculate that these may play some role in function or cytoskeletal structure.
In conclusion, the bromobimanes appear to be a useful addition to the armamentarium of those who treat molecules to tag them. The ease of the labeling reaction, the strong fluorescence of the labeled materials, the chemical stability of the bimane label through various treatments, and the photostability of the labeled products are factors that suggest a wide applicability of the bimane labels to biological and biochemical problems. 
